At this time, posts about Daewoong are rapidly increasing on portals and stock communities. Today, foreigners have sold a net 83,822 shares of Daewoong, while institutions have bought a net 31,000 shares, according to provisional data. Daewoong is known as an investment holding company specializing in healthcare and the bio industry.


As of 12:30 PM on the 11th, Daewoong's stock price rose 24.27% from the previous day to 53,000 KRW, with a trading volume of 16,656,732 shares, which is 273.91% of the 5-day average trading volume. On December 1st, Daewoong became a market issue with the headline "Daewoong Pharmaceutical's COVID-19 treatment clinical support is soaring."


In addition to Daewoong, posts from investors are also surging for KPX Life Science (114450), Korea Information Certificate (053300), and MP Group (065150).



※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing